Fuel prices in India have seen another increase, with petrol and diesel rates rising by approximately Rs 0.87 and Rs 0.91 per ...

Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune ...

Knowing what these tests are looking for and what the results mean can really help you catch any blood sugar issues before they become serious health concerns. While one abnormal reading does not ...

Diabetes is diagnosed using blood tests that measure glucose (sugar) levels. In the early stages of the disease, symptoms may not be obvious, making routine screening essential for those at risk, such ...

A Lancet Regional Health study warns that HbA1c tests, the "gold standard" for diabetes, often fail in India due to anemia, thalassemia, sickle cell disease, and G6PD deficiency, which alter red blood ...

Novo Nordisk NVO announced positive top-line data from a late-stage study in its global REIMAGINE clinical study program for a next-generation pipeline candidate, CagriSema, for treating adults with ...

(RTTNews) - Danish drug maker Novo Nordisk A/S (NVO, NOVOB.CO, NOV.DE) announced late Monday headline results from REIMAGINE 2 trial, in which CagriSema demonstrated both superior HbA1c reduction and ...

Tirzepatide was superior to placebo in lowering HbA1c and reducing BMI in children and adolescents with type 2 diabetes. Topline results were announced from a phase 3 trial evaluating tirzepatide in ...

For adults with stage 4-5 CKD, an HbA1c range of 6.7% to 7.1% may be optimal for reducing macrovascular and microvascular complications. In advanced chronic kidney disease (CKD) and diabetes (type 1 ...

Diabetes mellitus (DM) and tuberculosis (TB) are significant global health challenges that complicate diagnosis, treatment, and management due to their interrelated nature. DM increases TB risk and ...

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor ...